India Again Requests Trial Protocols from Combo Drug Manufacturers

The Drug Controller General of India asked manufacturers twice last year to submit Phase IV trial protocols— once in June and again in September — but most drugmakers have still not fulfilled the regulatory requirement.
Source: Drug Industry Daily